Impact of Sinus Surgery on Pseudomonal Airway Colonization, Bronchiolitis Obliterans Syndrome and Survival in Cystic Fibrosis Lung Transplant Recipients
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background: Lung transplantation (LTx) is a therapy for patients with cystic fibrosis (CF) end-stage lung disease. Pseudomonal airway colonization (PAC) is common in CF. Objectives: We investigated the influence of post-transplant sinus surgery and daily nasal douching on PAC after LTx and the influence of PAC on survival and bronchiolitis obliterans syndrome (BOS). Methods: CF patients transplanted at our centre were included (November 1992 to December 2009). Clinical data, including microbiological data before and after LTx were collected. Survival and BOS following LTx were compared for CF recipients with and without PAC by Kaplan-Meier statistics and Cox regression analysis. Results: Ninety-four CF patients were transplanted, of whom 82 (87%) underwent sinus surgery after transplantation, and 65% of 66 patients with pre-transplant PAC had persistent PAC after transplantation. Upper and lower PAC is related. Patients without PAC after transplantation had a significantly better survival rate, and BOS was less frequent with a later onset. PAC was the only significant parameter for the development of BOS stage 2 in the multivariate analysis for cytomegalovirus infection, acute rejection and PAC. Conclusions: Sinus surgery and daily nasal douching reduced PAC in LTx recipients. Absence of post-transplant PAC had a positive impact on post-transplant survival and the development of BOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Post-transplant infectious recolonization in CF is thought to be related to sinus or other upper airway reservoirs and is associated with increased risk of graft dysfunction.(263, 264)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [264]
Citations
Cites
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
Estenne, M., Maurer, J. R., Boehler, A., Egan, J. J., Frost, A., Hertz, M., Mallory, G. B., Snell, G. I., & Yousem, S. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00398-4 · Cited by 1,274
Self-citationOrens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
Yousem, S. A., Berry, G. J., Cagle, P. T., Chamberlain, D. W., Husain, A. N., Hruban, R. H., Marchevsky, A. M., Ohori, N. P., Ritter, J. M., Stewart, S., et al. (1996) · PubMed · Cited by 888
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Botha, P., Archer, L., Anderson, R. L., Lordan, J., Dark, J. H., Corris, P. A., Gould, K., & Fisher, A. J. (2008) · Transplantation · doi:10.1097/tp.0b013e31816651de · Cited by 274
Post-transplant bronchiolitis obliterans
Boehler, A., & Estenne, M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00039103 · Cited by 207
Self-citationConcordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis
Mainz, J. G., Naehrlich, L., Schien, M., Kading, M., Schiller, I., Mayr, S., Schneider, G., Wiedemann, B., Wiehlmann, L., Cramer, N., et al. (2009) · Thorax · doi:10.1136/thx.2008.104711 · Cited by 195
Vos, R., Vanaudenaerde, B. M., Geudens, N., Dupont, L. J., Van Raemdonck, D. E., & Verleden, G. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00128607 · Cited by 178
Holzmann, D., Speich, R., Kaufmann, T., Laube, I., Russi, E. W., Simmen, D., Weder, W., & Boehler, A. (2004) · Transplantation · doi:10.1097/01.tp.0000100467.74330.49 · Cited by 127
Self-citationHadjiliadis, D., Steele, M. P., Chaparro, C., Singer, L. G., Waddell, T. K., Hutcheon, M., Davis, R. D., Tullis, D. E., Palmer, S. M., & Keshavjee, S. H. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.05.018 · Cited by 127
Cited by
Verleden, G. M., Glanville, A. R., Lease, E. D., Fisher, A. J., Calabrese, F., Corris, P. A., Ensor, C. R., Gottlieb, J., Hachem, R. R., Lama, V., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.009 · Cited by 952
“51 At present, only prophylactic treatment with azithromycin has been demonstrated to significantly reduce the prevalence of BOS in a randomized clinical trial.”
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
“263,264 264-267 Non-infectious comorbidities include malnutrition, which is common in CF patients approaching transplant and represents a potentially modifiable risk factor.”
BackgroundCiofu, O., Tolker-Nielsen, T., Jensen, P. Ø., Wang, H., & Høiby, N. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.017 · Cited by 306
Multidrug-resistant bacteria in solid organ transplant recipients
Cervera, C., van Delden, C., Gavaldà, J., Welte, T., Akova, M., & Carratalà, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12687 · Cited by 167
“aeruginosa from a sinus reservoir [143,144].”
Phenotypes of Chronic Rhinosinusitis
Cho, S., Hamilos, D. L., Han, D. H., & Laidlaw, T. M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.12.021 · Cited by 169
Comprehensive review on endonasal endoscopic sinus surgery
Weber, R., & Hosemann, W. G. (2015) · GMS. Current topics in otorhinolaryngology - head and neck surgery · doi:10.3205/cto000123 · Cited by 163
“One article in literature reports on negetive results [813], another one describes better results after intensive local therapy [814].”
ResultAanæs, K. (2013) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(13)00150-1 · Cited by 119
Grassmé, H., Henry, B., Ziobro, R., Becker, K. A., Riethmüller, J., Gardner, A. I., Seitz, A. P., Steinmann, J., Lang, S., Ward, C., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.05.001 · Cited by 115
Management of the upper airway in cystic fibrosis
Illing, E. A., & Woodworth, B. A. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000107 · Cited by 96
Nosocomial infections within the first month of solid organ transplantation
Dorschner, P. B., McElroy, L. M., & Ison, M. G. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12203 · Cited by 86
“De novo colonization after transplantation was much more strongly associated with BOS than pre-transplant colonization that persisted through the perioperative period (97).”
BackgroundInfluentialCiofu, O., Johansen, H. K., Aanæs, K., Wassermann, T., Alhede, M., von Buchwald, C., & Høiby, N. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.02.004 · Cited by 86
Southern, K. W., Castellani, C., Lammertyn, E. J., Smyth, A. R., VanDevanter, D. R., Koningsbruggen-Rietschel, S. V., Barben, J., Bevan, A., Brokaar, E. J., Collins, S., et al. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.10.002 · Cited by 83
Aanæs, K., Johansen, H. K., Skov, M., Buchvald, F. F., Hjuler, T., Pressler, T., Høiby, N., Nielsen, K. G., & von Buchwald, C. (2013) · Rhinology Journal · doi:10.4193/rhin12.207 · Cited by 72
Alanin, M. C., Aanæs, K., Høiby, N., Pressler, T., Skov, M., Nielsen, K. G., Johansen, H. K., & von Buchwald, C. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21873 · Cited by 65
Respiratory infections in patients with cystic fibrosis undergoing lung transplantation
Lobo, L. J., & Noone, P. G. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70162-0 · Cited by 64
Lung transplantation for cystic fibrosis
Morrell, M. R., & Pilewski, J. M. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.11.008 · Cited by 56
Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis
Tipirneni, K. E., & Woodworth, B. A. (2017) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-017-0139-3 · Cited by 61
Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients
Ramos, K. J., Guimbellot, J. S., Valapour, M., Bartlett, L., Wai, T. H., Goss, C. H., Pilewski, J. M., Faro, A., & Diamond, J. M. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.04.009 · Cited by 49
Bacterial infections in lung transplantation
McCort, M., MacKenzie, E. L., Pursell, K. J., & PITRAK, D. L. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-12 · Cited by 57
“Patients with CF are at increased risk for both early and delayed bacterial pneumonia after lung transplantation due to underlying bacterial colonization with MDR pathogens, as well as ongoing dysfunction of native sinus tracts and upper airways (33,52,56,57,62-64,124).”
BackgroundCorrelation between sinus and lung cultures in lung transplant patients with cystic fibrosis
Choi, K. J., Cheng, T. Z., Honeybrook, A. L., Gray, A., Snyder, L. D., Palmer, S. M., Hachem, R. A., & Jang, D. W. (2017) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22067 · Cited by 46
Shah, P. D., Lowery, E. M., Chaparro, C., Visner, G. A., Hempstead, S. E., Abraham, J. M., Bhakta, Z. N., Carroll, M., Christon, L., Danziger‐Isakov, L. A., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.011 · Cited by 47
The Human Respiratory Microbiome: Implications and Impact
Mitchell, A. B., & Glanville, A. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617441 · Cited by 43
Alanin, M. C., Aanæs, K., Høiby, N., Pressler, T., Skov, M., Nielsen, K. G., Taylor-Robinson, D. C., Waldmann, E., Johansen, H. K., & von Buchwald, C. (2016) · Rhinology Journal · doi:10.4193/rhino15.347 · Cited by 50
The role of innate immunity in the long-term outcome of lung transplantation
Kawashima, M., & Juvet, S. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.20 · Cited by 39
“It is well established that Pseudomonas aeruginosa colonization and infection are risk factors of CLAD (88-92).”
BackgroundChallenges in the use of highly effective modulator treatment for cystic fibrosis
Ramos, K. J., Pilewski, J. M., & Taylor‐Cousar, J. L. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.01.007 · Cited by 40
Muynck, B. D., Herck, A. V., Sacreas, A., Heigl, T., Kaes, J., Vanstapel, A., Verleden, S. E., Neyrinck, A., Ceulemans, L. J., Raemdonck, D. E. V., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01720-2020 · Cited by 37
Sphingolipids as targets for inhalation treatment of cystic fibrosis
Becker, K. A., Riethmüller, J., Seitz, A. P., Gardner, A. I., Boudreau, R. M., Kamler, M., Kleuser, B., Schuchman, E. H., Caldwell, C. C., Edwards, M. J., et al. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.015 · Cited by 36
The burden of sinus disease in cystic fibrosis lung transplant recipients
Morlacchi, L. C., Greer, M., Tudorache, I., Blasi, F., Welte, T., Haverich, A., Mainz, J. G., & Gottlieb, J. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12924 · Cited by 32
Chronic rhinosinusitis in patients with cystic fibrosis—Current management and new treatments
Johnson, B. J., Choby, G. W., & O’Brien, E. K. (2020) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.401 · Cited by 32
“paper reported that patients with negative bronchoalveolar lavage and nasal aspirates had improved survival at 5 years after LuTx (86% vs 57%) with fewer patients having BOS stages 1 and 2 (as defined by FEV1 66%-80% and 51%-65% of baseline, respectively).(60,61) Overall, these studies indicate that ESS after LuTx may…”
BackgroundOrgan Transplantation for Cystic Fibrosis
Morrell, M. R., Kiel, S., & Pilewski, J. M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-3399554 · Cited by 32
Alanin, M. C., Aanæs, K., Høiby, N., Pressler, T., Skov, M., Nielsen, K. G., Taylor-Robinson, D. C., Waldmann, E., Krogh‐Johansen, H., & von Buchwald, C. (2017) · Rhinology Journal · doi:10.4193/rhin15.347 · Cited by 27
“However, our experience supported by other prospective studies using a protocolled postoperative regimen (15,35,38) indicate that combined ESS and adjuvant therapy promotes the best outcome both concerning CRS management and in reducing airway colonization with GNB; however, revision surgeries may be required.”
ResultLung transplantation in cystic fibrosis patients with difficult to treat lung infections
Dupont, L. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000431 · Cited by 29
The lung microbiome after lung transplantation
Becker, J. B., Poroyko, V. A., & Bhorade, S. M. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.890518 · Cited by 31
Systemic and Odontogenic Etiologies in Chronic Rhinosinusitis
Kuan, E. C., & Suh, J. D. (2016) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2016.08.008 · Cited by 28
“Some experts have found that ESS not only seems to decrease Pseudomonas colonization and subsequent bronchopulmonary infections, but also decreases the risk of bronchiolitis obliterans and improves posttransplant survival.(26,27) In contrast, Leung and colleagues(28) found in a retrospective review of 87 CF lung trans…”
ResultSchwarz, C., Schulte-Hubbert, B., Bend, J., Abele‐Horn, M., Baumann, I., Bremer, W., Brunsmann, F., Dieninghoff, D., Eickmeier, O., Ellemunter, H., et al. (2018) · Pneumologie · doi:10.1055/s-0044-100191 · Cited by 29
“Andreas Jung; Kinderspital Zürich, Abteilung Pneumologie, Zürich, Schweiz PD Dr. med.”
InfluentialSafety of endoscopic sinus surgery in children with cystic fibrosis
Tumin, D., Hayes, D., Kirkby, S. E., Tobias, J. D., & McKee, C. T. (2017) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2017.04.034 · Cited by 23
Hirama, T., Tomiyama, F., Notsuda, H., Watanabe, T., Watanabe, Y., Oishi, H., & Okada, Y. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01634-z · Cited by 25
Outcomes of endoscopic sinus surgery in adult lung transplant patients with cystic fibrosis
Luparello, P., Lazio, M. S., Voltolini, L., Borchi, B., Taccetti, G., & Maggiore, G. (2019) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-019-05308-9 · Cited by 24
Pritchard, J., Thakrar, M. V., Somayaji, R., Surette, M. G., Rabin, H. R., Helmersen, D., Lien, D. C., Purighalla, S., Waddell, B. J. M., & Parkins, M. D. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.11.004 · Cited by 21
“aeruginosa colonization persists in the sinuses following lung transplantation and can serve as reservoir for recurrent infection of the graft [17,18].”
BackgroundSpielman, D. B., Beswick, D. M., Kimple, A. J., Senior, B. A., Aanæs, K., Woodworth, B. A., Schlosser, R. J., Lee, S. J., Cho, D., Adappa, N. D., et al. (2022) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22953 · Cited by 24
The lung microbiome and transplantation
Mitchell, A. B. (2019) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000631 · Cited by 21
Dugger, D. T., Fung, M., Zlock, L. T., Caldera, S., Sharp, L. Z., Hays, S. R., Singer, J. P., Leard, L. E., Golden, J. A., Shah, R., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100055 · Cited by 20
Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Respiratory Research · doi:10.1186/s12931-021-01724-w · Cited by 18
The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis
Chin, M., Aaron, S. D., & Bell, S. C. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2016.11.030 · Cited by 20
Diagnostic performance of electronic nose technology in chronic lung allograft dysfunction
Wijbenga, N., Hoek, R. A. S., Mathot, B. J., Seghers, L., Moor, C. C., Aerts, J. G. J. V., Bos, D., Manintveld, O. C., & Hellemons, M. E. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.09.009 · Cited by 19
Mainz, J. G., Gerber, A. R., Lorenz, M., Michl, R., Hentschel, J., Nader, A., Beck, J. F., Pletz, M. W., & Müller, A. (2015) · Case Reports in Infectious Diseases · doi:10.1155/2015/438517 · Cited by 16
Sinus biofilms in patients with cystic fibrosis: is adjusted eradication therapy needed?
Aanæs, K., Eickhardt, S. R., Johansen, H. K., von Buchwald, C., Skov, M., Høiby, N., & Bjarnsholt, T. (2014) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-014-3322-x · Cited by 15
Prevention of chronic rejection after lung transplantation
Herck, A. V., Verleden, S. E., Vanaudenaerde, B. M., Verleden, G. M., & Vos, R. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.11.85 · Cited by 17
“could reveal a significant decrease of CR (183-185).”
BackgroundWilson, P., Lambert, C., Carr, S. B., & Pao, C. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.003 · Cited by 12
“This has been shown to be of particular importance in the post-transplant population [9–11].”
BackgroundA Practical Approach to Refractory Chronic Rhinosinusitis
McCoul, E. D., & Tabaee, A. (2016) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2016.08.014 · Cited by 11
Surgical Management of Chronic Rhinosinusitis in Cystic Fibrosis
Zheng, Z., Safi, C., & Gudis, D. A. (2019) · Medical Sciences · doi:10.3390/medsci7040057 · Cited by 13
“The absence of persistent airway pathogenic colonization was associated with less frequent and delayed development of BOS and increased overall survival [28].”
BackgroundUpdate on Lung Transplantation for Cystic Fibrosis
Pilewski, J. M. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.07.002 · Cited by 10
The impact of chronic rhinosinusitis on long-term survival in lung transplantation recipients
Kariya, S., Okano, M., Oto, T., Higaki, T., Haruna, T., Noda, Y., & Nishizaki, K. (2016) · Acta Oto-Laryngologica · doi:10.1080/00016489.2016.1247497 · Cited by 8
“[6,7] reported that sinus surgery and daily nasal douching had a positive effect on post-trans-”
BackgroundUpper Airway Disease in Adults with Cystic Fibrosis in the Era of CFTR Modulators
Uyttebroek, S., Dupont, L., Jorissen, M., & Gerven, L. V. (2023) · The Laryngoscope · doi:10.1002/lary.30642 · Cited by 9
Is Endoscopic Sinus Surgery Beneficial Post Lung Transplant in Cystic Fibrosis Patients?
Hughes, A. L., & Adil, E. A. (2020) · The Laryngoscope · doi:10.1002/lary.28916 · Cited by 7
“The same group published an update of their experience with ESS post lung transplant.(4) From 1992 to 2009, they identified 82 lung transplant recipients with complete data.”
BackgroundComparison of endoscopic sinus surgery timing in lung transplant patients with cystic fibrosis
Johnson, J. R., Hwang, P. H., Nayak, J. V., & Patel, Z. M. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22935 · Cited by 6
Faro, A., & Weymann, A. (2016) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2016.04.010 · Cited by 6
Meier, M., Schuurmans, M. M., Vital, D., İnci, İ., Holzman, D., & Soyka, M. (2023) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-023-08028-3 · Cited by 4
Self-citationKleuser, B., Schumacher, F., & Gulbins, E. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_700 · Cited by 6
Kapnadak, S. G., Kicska, G., Ramos, K. J., Marshall, D. A., Carroll, T. Y., Pipavath, S. N. J., Mulligan, M. S., Goss, C. H., & Aitken, M. L. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.07.015 · Cited by 4
Transplantation pulmonaire pour mucoviscidose et autres bronchectasies
Renaud-Picard, B., Tissot, A., Burgel, P., Grenet, D., MIRANDA, S. D., & Coiffard, B. (2023) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.12.011 · Cited by 5
Miglani, A., Brar, T. K., & Lal, D. (2022) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2022.09.013 · Cited by 3
Lung Transplantation: Selection of Candidates
Thomas, C., Williams, M., & Shlobin, O. A. (2023) · OBM Transplantation · doi:10.21926/obm.transplant.2304197 · Cited by 2
Burdis, N., Bradford, M. C., Heltshe, S. L., Milinic, T., McElvaney, O. J., Lease, E. D., Goss, C. H., Kapnadak, S. G., Guthrie, B. L., & Ramos, K. J. (2025) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2025.06.005 · Cited by 2
Early Postoperative Management of Lung Transplant Recipients
Trinh, B. N., Brzeziński, M., & Kukreja, J. (2022) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2021.11.006 · Cited by 3
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study
Pascale, R., Tazza, B., Amicucci, A., Salvaterra, E., DOLCI, G. G., Antonacci, F., Baiocchi, M., Pastore, S., Ambretti, S., Peghin, M., et al. (2024) · Transplant International · doi:10.3389/ti.2024.13245 · Cited by 4
Spezifische Infektionen bei Organtransplantationen
Cornberg, M., Schlevogt, B., Rademacher, J., Schwarz, A., Sandherr, M., & Maschmeyer, G. (2016) · Der Internist · doi:10.1007/s00108-015-3807-8 · Cited by 2
Mainz, J. G., Arnold, C., Gerber, A. R., Rödel, J., Cramer, N., Mentzel, H., Beck, J. F., & Tümmler, B. (2016) · Sinusitis · doi:10.3390/sinusitis1010049 · Cited by 1
“[4,17].”
Muqueuse naso-sinusienne et mucoviscidose
Prulière-Escabasse, V. (2019) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2019.03.005 · Cited by 1
Cystic Fibrosis and Chronic Rhinosinusitis: Diagnosis and Medical Management
Aanæs, K. (2020) · Springer eBooks · doi:10.1007/978-3-030-50330-7_8 · Cited by 1
Evaluación pretrasplante en otorrinolaringología
Carolina Oliva, G., Paul Boettiger, B., & Lara Fernández, R. (2020) · Revista de otorrinolaringología y cirugía de cabeza y cuello · doi:10.4067/s0718-48162020000300352 · Cited by 1
Pulmonary Pathology in Agammaglobulinemia: Diagnosis and Treatment
Baumann, U. (2015) · Rare diseases of the immune system · doi:10.1007/978-3-319-22714-6_3
Management of Cellular and Humoral Rejection: Prevention, Diagnosis, and Treatment
Lease, E. D., & Raghu, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-91184-7_12
Manifestaciones rinosinusales de la mucoviscidosis
Prulière-Escabasse, V. (2020) · EMC - Otorrinolaringología · doi:10.1016/s1632-3475(20)43998-0
Cystic Fibrosis and Chronic Rhinosinusitis: Surgical Management and Outcomes
Spielman, D. B., Safi, C., Overdevest, J. B., & Gudis, D. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-50330-7_9
Shah, P. D., Lowery, E. M., Chaparro, C., Visner, G. A., Hempstead, S. E., Abraham, J. M., Bhakta, Z. N., Carroll, M., Christon, L., Danziger‐Isakov, L. A., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.012
RetractedLung Transplantation for Cystic Fibrosis
Pilewski, J. M. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_12
Lung Transplantation for Cystic Fibrosis
Merlo, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00263-8
Cystic Fibrosis Chronic Rhinosinusitis
Chung, S. Y., Gudis, D. A., & Schlosser, R. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-33199-2_21
Hirama, T., Tomiyama, F., Notsuda, H., Watanabe, T., Watanabe, Y., Oishi, H., & Okada, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15162149
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478473
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478467
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478476
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478479
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478458
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478461
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478485
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478482
Påhlman, L. I., Manoharan, L., & Aspelund, A. S. (2021) · Figshare · doi:10.6084/m9.figshare.14478470
Akita, T., Nishijima, H., Sato, T., Konoeda, C., Kawashima, M., Kagoya, R., Ogawa, K., Horikiri, K., Sato, M., & Kondo, K. (2026) · Auris Nasus Larynx · doi:10.1016/j.anl.2026.02.001
Ertan, S. N., Alomarı, O., Mokresh, M. E., Eyvazova, H., Güney, B., Caliskan, C. S., Yegin, R., Evman, S., & Evman, M. D. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-026-10158-3
“Of these, ten were rated as good quality [2 – 4, 6, 8, 25 – 28, 32], while the remaining two studies were considered fair quality [7, 9 ] due to limited available data.”
Influential
Metadata
- Authors
- Vital, D., Hofer, M., Benden, C., Holzmann, D., & Boehler, A.
- Affiliations
- University Hospital Zurich (CH)
- Venue
- Respiration
- Publisher
- S. Karger AG
- Published
- 2012-08-22
- Volume
- 86
- Issue
- 1
- Pages
- 25-31
- ISSN
- 0025-7931 (ISSN-L)
- 1423-0356
- OpenAlex
- W2037338014
- Cited by
- 91
- References
- 25
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 20 · 2020: 11 · 2019: 6 · 2018: 5 · 2017: 9 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 4
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Respiration (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- cystic fibrosis, lung transplantation, sinus surgery, Pseudomonas aeruginosa, airway colonization, bronchiolitis obliterans syndrome, nasal douching, survival, cytomegalovirus infection, acute rejection
- MeSH terms
- Adult, Bronchiolitis Obliterans, Bronchoalveolar Lavage Fluid, Cystic Fibrosis, Female, Humans, Male, Paranasal Sinuses, Pseudomonas Infections, Retrospective Studies, Proportional Hazards Models, Lung Transplantation, Treatment Outcome, Disease-Free Survival, Kaplan-Meier Estimate, Nasal Lavage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.